160 related articles for article (PubMed ID: 38359363)
1. CEBPA double mutations associated with ABO antigen weakness in hematologic diseases.
Choi SJ; Kim HK; Suh EJ; Kwon SS; Shin S; Lee ST; Kim S
Blood Adv; 2024 Mar; 8(6):1487-1493. PubMed ID: 38359363
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations.
Tien FM; Yao CY; Tsai XC; Lo MY; Chen CY; Lee WH; Lin CC; Kuo YY; Peng YL; Tseng MH; Wu YS; Liu MC; Lin LI; Chuang MK; Ko BS; Yao M; Tang JL; Chou WC; Hou HA; Tien HF
Blood Cancer J; 2024 Jan; 14(1):15. PubMed ID: 38253683
[TBL] [Abstract][Full Text] [Related]
3. Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia.
Hollink IH; van den Heuvel-Eibrink MM; Arentsen-Peters ST; Zimmermann M; Peeters JK; Valk PJ; Balgobind BV; Sonneveld E; Kaspers GJ; de Bont ES; Trka J; Baruchel A; Creutzig U; Pieters R; Reinhardt D; Zwaan CM
Haematologica; 2011 Mar; 96(3):384-92. PubMed ID: 21134981
[TBL] [Abstract][Full Text] [Related]
4. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.
Schlenk RF; Döhner K; Krauter J; Fröhling S; Corbacioglu A; Bullinger L; Habdank M; Späth D; Morgan M; Benner A; Schlegelberger B; Heil G; Ganser A; Döhner H;
N Engl J Med; 2008 May; 358(18):1909-18. PubMed ID: 18450602
[TBL] [Abstract][Full Text] [Related]
5. [ABO gene subtypes and gene expression analysis in three cases of hematological malignancies patients].
Ma CM; Wu QS; Yu TT; Wei SP; Wang F; Fang JC; Nie DJ; Yuan LL; Zhang Y; Chen X; Liu M; Zhou XS; Zhou J; Liu HX
Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(43):3443-3447. PubMed ID: 33238676
[No Abstract] [Full Text] [Related]
6. Mutational landscape of patients with acute myeloid leukemia or myelodysplastic syndromes in the context of RUNX1 mutation.
Wang K; Zhou F; Cai X; Chao H; Zhang R; Chen S
Hematology; 2020 Dec; 25(1):211-218. PubMed ID: 32476595
[No Abstract] [Full Text] [Related]
7. Reduction of blood group A antigen on erythrocytes in a patient with myelodysplastic syndrome harboring somatic mutations in RUNX1 and GATA2.
Hayakawa A; Sano R; Takahashi Y; Okawa T; Kubo R; Harada M; Fukuda H; Yokohama A; Handa H; Kawabata-Iwakawa R; Tsuneyama H; Tsukada J; Kominato Y
Transfusion; 2022 Feb; 62(2):469-480. PubMed ID: 34918362
[TBL] [Abstract][Full Text] [Related]
8. Favorable prognosis of biallelic CEBPA gene mutations in acute myeloid leukemia patients: a meta-analysis.
Li HY; Deng DH; Huang Y; Ye FH; Huang LL; Xiao Q; Zhang B; Ye BB; Lai YR; Mo ZN; Liu ZF
Eur J Haematol; 2015 May; 94(5):439-48. PubMed ID: 25227715
[TBL] [Abstract][Full Text] [Related]
9. Mutational spectrum of acute myeloid leukemia patients with double
Su L; Tan Y; Lin H; Liu X; Yu L; Yang Y; Liu S; Bai O; Yang Y; Jin F; Sun J; Liu C; Liu Q; Gao S; Li W
Oncotarget; 2018 May; 9(38):24970-24979. PubMed ID: 29861846
[TBL] [Abstract][Full Text] [Related]
10. [Allo-HSCT for acute myeloid leukemia with myelodysplastic-related changes: a clinical analysis].
Zhang HX; Pang AM; Chen X; Zhang RL; Zhai WH; Ma QL; Yang DL; Wei JL; He Y; Feng SZ; Han MZ; Jiang EL
Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):814-822. PubMed ID: 34788920
[No Abstract] [Full Text] [Related]
11. Frequency and clinical impact of WT1 mutations in the context of CEBPA-mutated acute myeloid leukemia.
Wang T; Hua H; Wang Z; Wang B; Cao L; Qin W; Wu P; Cai X; Chao H; Lu X
Hematology; 2022 Dec; 27(1):994-1002. PubMed ID: 36066283
[TBL] [Abstract][Full Text] [Related]
12. Molecular evaluation of CEBPA gene mutation in normal karyotype acute myeloid leukemia: a comparison of two methods and report of novel CEBPA mutations from Indian acute myeloid leukemia patients.
Ahmad F; Rajput S; Mandava S; Das BR
Genet Test Mol Biomarkers; 2012 Jul; 16(7):707-15. PubMed ID: 22731647
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations.
Green CL; Koo KK; Hills RK; Burnett AK; Linch DC; Gale RE
J Clin Oncol; 2010 Jun; 28(16):2739-47. PubMed ID: 20439648
[TBL] [Abstract][Full Text] [Related]
14. GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution.
Hou HA; Lin YC; Kuo YY; Chou WC; Lin CC; Liu CY; Chen CY; Lin LI; Tseng MH; Huang CF; Chiang YC; Liu MC; Liu CW; Tang JL; Yao M; Huang SY; Ko BS; Hsu SC; Wu SJ; Tsay W; Chen YC; Tien HF
Ann Hematol; 2015 Feb; 94(2):211-21. PubMed ID: 25241285
[TBL] [Abstract][Full Text] [Related]
15. [Restratifying the prognosis of acute myeloid leukemia patients with CEBPA double mutations based on CSF3R mutations and measurable residual disease].
Su L; Tan YH; Lin H; Han W; Yang YP; Liu XL; Sun JN; Liu QJ; Gao SJ
Zhonghua Xue Ye Xue Za Zhi; 2022 Dec; 43(12):1021-1027. PubMed ID: 36709108
[No Abstract] [Full Text] [Related]
16. Combined testing for CCAAT/enhancer-binding protein alpha (CEBPA) mutations and promoter methylation in acute myeloid leukemia demonstrates shared phenotypic features.
Szankasi P; Ho AK; Bahler DW; Efimova O; Kelley TW
Leuk Res; 2011 Feb; 35(2):200-7. PubMed ID: 20970189
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor mutations in myelodysplastic/myeloproliferative neoplasms.
Ernst T; Chase A; Zoi K; Waghorn K; Hidalgo-Curtis C; Score J; Jones A; Grand F; Reiter A; Hochhaus A; Cross NC
Haematologica; 2010 Sep; 95(9):1473-80. PubMed ID: 20421268
[TBL] [Abstract][Full Text] [Related]
18. Transfusion efficacy of ABO major-mismatched platelets (PLTs) in children is inferior to that of ABO-identical PLTs.
Julmy F; Ammann RA; Taleghani BM; Fontana S; Hirt A; Leibundgut K
Transfusion; 2009 Jan; 49(1):21-33. PubMed ID: 18774963
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group.
Matsuo H; Kajihara M; Tomizawa D; Watanabe T; Saito AM; Fujimoto J; Horibe K; Kodama K; Tokumasu M; Itoh H; Nakayama H; Kinoshita A; Taga T; Tawa A; Taki T; Tanaka S; Adachi S
Blood Cancer J; 2014 Jul; 4(7):e226. PubMed ID: 25014773
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of Weak ABO Antigen and Normal ABO Antigen in Patients with Acute Leukemia].
Shao M; Lyu XP; Tang P; Yang QK; Zhu WT; Song J; Kong YK; Wang J; Sun L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1307-1313. PubMed ID: 29070100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
